Biologics for pediatric moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis

Huang, I-HsinI-HsinHuangYu, Chia-LingChia-LingYuTai, Cheng-ChenCheng-ChenTaiYU-KANG TUChi, Ching-ChiChing-ChiChi2023-03-252023-03-252022-091610-0379https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138689020&doi=10.1111%2fddg.14832&partnerID=40&md5=5a4ef4450f35a70959b9e0b8c1217e60https://scholars.lib.ntu.edu.tw/handle/123456789/629669To compare the efficacy and safety of biologic treatments for moderate-to-severe pediatric psoriasis approved by the US Food and Drug Administration and European Medicines Agency.enETANERCEPT TREATMENT; CHILDHOOD PSORIASIS; ADOLESCENTS; CHILDREN; EFFICACY; SAFETY; CELLS[SDGs]SDG3Biologics for pediatric moderate-to-severe plaque psoriasis: a systematic review and network meta-analysisjournal article10.1111/ddg.14832360284702-s2.0-85138689020WOS:000846462300001https://api.elsevier.com/content/abstract/scopus_id/85138689020